Targeting Interferon-α Increases Antitumor Efficacy and Reduces Hepatotoxicity of E1A-mutated Spread-enhanced Oncolytic Adenovirus

This publication has 44 references indexed in Scilit:

• Deletion of VAI and VAII RNA Genes in the Design of Oncolytic Adenoviruses
  Human Gene Therapy, 2006
• Second-Generation Replication-Competent Oncolytic Adenovirus Armed with Improved Suicide Genes and ADP Gene Demonstrates Greater Efficacy without Increased Toxicity
  Molecular Therapy, 2006
• VSV-tumor selective replication and protein translation
  Oncogene, 2005
• A critical function for type I interferons in cancer immunoediting
  Nature Immunology, 2005
• Impact of E1a Modifications on Tumor-Selective Adenoviral Replication and Toxicity
  Molecular Therapy, 2004
• A Tumor-Targeted and Conditionally Replicating Oncolytic Adenovirus Vector Expressing TRAIL for Treatment of Liver Metastases
  Molecular Therapy, 2004
• Intratumoral Spread of Wild-Type Adenovirus Is Limited After Local Injection of Human Xenograft Tumors: Virus Persists and Spreads Systemically at Late Time Points
  Human Gene Therapy, 2003
• Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region
  Gene Therapy, 2001
• Evaluation of E1-Mutant Adenoviruses as Conditionally Replicating Agents for Cancer Therapy
  Molecular Therapy, 2000
• In Vivo Tumor Suppression by Adenovirus-Mediated Interferon alpha2b Gene Delivery
  Human Gene Therapy, 1999